Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Why Do Active Funds Underperform Benchmark? This overview breaks down fees, manager skill, and market efficiency to explain gaps in performance and how to navigate them.
22,441 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Think it's late invest? You're not out of luck. Even if retirement feels distant, small, steady actions can compound ...
January brought a standout move in midstream equities as energy transfer's units surged. This in-depth look explains ...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
The pace of Social Security increases continues into 2026, with the average social security check edging higher. This...
In February, the Mortgage Credit Availability Index rose 1.1% to 107.1, signaling looser lending in conventional prog...
A fresh projection suggests a 2.8% Social Security COLA for 2027, renewing concerns that benefits may not keep pace w...
A $3 million retirement nest egg offers substantial income options, but taxes, Medicare costs, and withdrawal strateg...
Rising costs are changing what an engagement ring represents for many couples. This article explores why engagement r...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
MSGM's Q1 2026 commentary offers a clearer view of the year ahead for investors. This article decodes the msgm 2026 e...
Investors are watching canaan (can) 2026 earnings as CAN navigates a shifting mining market. This guide breaks down t...